Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.
Researchers sought to assess the safety, tolerability, and immunogenicity of a novel pneumococcal conjugate vaccine (V114) in patients at risk for pneumococcal disease.
The researchers assessed the efficacy and safety of sequential mechanical ventilation in the treatment of tuberculosis with respiratory failure.
Previously, the initial loading dose of Nuzyra for CABP was administered only by IV infusion.
Results showed both trials of leronlimab did not meet primary or secondary endpoints.
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
The Food and Drug Administration has granted Fast Track designation to NanoFlu (Novavax) for seasonal influenza vaccination in adults ≥65 years.
Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities.